Dow Pharma Solutions — a business unit of the DowDuPont Specialty Products Division — addresses the toughest challenges its customers face in pharmaceutical applications, drug delivery systems and productivity enhancement at CPhI Worldwide
Dow’s portfolio of trusted solutions for the pharmaceutical markets now includes products based on the heritage Dow Corning silicone technology platform, to enable optimal drug delivery systems across oral, transdermal and topical dosage forms.
At CPhI Worldwide, Dow will display customer samples and discuss the following technologies:
The innovative properties of AFFINISOL HPMCAS High Productivity grade to facilitate higher solids content for increased throughput while maintaining optimal solubility, earned the technology a nomination for CPhI’s Pharma Awards 2017. Winners to be announced 24 October during an onsite awards ceremony.
Dago Caceres said: “We constantly seek new ways to push our technologies to the next level and provide even better drug delivery performance for our customers. AFFINISOL is just one example of how we provide customised solutions to meet growing industry needs like solubility enhancement.”
Aligned with the trend for large molecule drugs and personalised medicine, Dow will also showcase its range of bio-pharma processing solutions for platinum catalysed pharma tubing and over-moulded assemblies.
Both are designed to meet the stringent performance and regulatory requirements of biopharmaceutical processes for fluids transportation in various upstream and downstream steps.
This technology is particularly crucial during the final filling step where the highly valuable final drug product is in direct contact with silicone tubing.
Jennifer Gemo, global segment leader for Dow BioPharma Processing, said: “Our presence at CPhI reinforces Dow’s commitment to the growth of the bio-pharmaceutical industry with solutions that perfectly fit to critical biopharma processes where component purity is key.”
In addition to its booth presence at CPhI, Dow experts will share insights during the pre-congress, three technical presentations and at the women in leadership forum. Topics for discussion, include:
Amina Faham, global pharma leader, said: “Empowering women in the pharma industry to push for the senior-level roles they deserve is the first step to make a dynamic change in workplace diversity. As more businesses, like ours advance diversity and inclusion, there will no longer be a lack of opportunity and availability for women to seize these roles.”
In this Dow-sponsored event, Faham and fellow women in leadership will share their perspective on strategies to build an inclusive environment and empower women to pave their routes to leadership roles. Register here.
To learn more about Dow’s pharmaceutical and medical technologies, visit CPhI booth #102A50 where experts will be available.